When and How to Treat Myopic Traction Maculopathy

Surgical technique should be chosen based on detailed evaluation.

Read Article
  • From Trials to Treatment

    Real World Applications in Medical and Surgical Retina

    Read Article
  • Laser Remains An Effective Treatment Option for DME

    Read Article


Visit @RetinaToday on Twitter

Articles From This Issue


Each Issue a Recipe


Medical Editors' Page

Every issue of Retina Today can be viewed as a recipe of sorts for better patient outcomes, each article an ingredient with the potential for enhancement. The topics may r…

Retina News

in AMD, Brolucizumab was Effective With 3-month Dosing Interval Brolucizumab (RTH258, formerly ESBA1008, Novartis) met its primary efficacy endpoint in two phase 3 clinical…

  • Diabetes Awareness Month
  • OCT-A Disease Education Resource Center
  • AMD Awareness Month
  • DME Disease Education Resource Center
  • Uveitis Resource Center
  • ZEISS OCT Angiography eNewsletter Series
  • AMD Disease Education Resource Center
  • NEWS


    First Patient Enrolled in USH2A Natural History Study

    The first patient has been enrolled in a 4-year natural history study of people with mutations in th…

    New Anti-VEGF Drug Promising for Wet Macular Degeneration

    A new antivascular endothelial growth-factor (VEGF) drug, OPT-302 (Opthea), appears to be safe and s…

    Contact Info

    Bryn Mawr Communications LLC
    1008 Upper Gulph Road, Suite 200
    Wayne, PA 19087

    Phone: 484-581-1800
    Fax: 484-581-1818

    Karen Roman

    Janet Burk

    About Retina Today

    Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.